This study showed that a protein II (Pll) In Neisseria gonorrhoeae, pili seem to function as primary effectors of attachmentt to eucaryotic cells (16, 17) . The presence of a nonpilus surface protein, protein II (Pll), also correlates with attachment (20). A strain of N. gonorrhoeae can express several Plls associated with various degrees of colony opacity (14), and at least one PII appears to be associated with opaque colony phenotype. Opaque colony variants of strain F62 attach better to HeLa 229 and Flow 2000 cells than do transparent colony variants (4). One PII (leukocyte association factor), from strain MS11, promotes attachment to leukocytes (6, 7, 17) . Other PIIs promote attachment to other types of eucaryotic cells (9, 15).
In Neisseria gonorrhoeae, pili seem to function as primary effectors of attachmentt to eucaryotic cells (16, 17) . The presence of a nonpilus surface protein, protein II (Pll), also correlates with attachment (20) . A strain of N. gonorrhoeae can express several Plls associated with various degrees of colony opacity (14) , and at least one PII appears to be associated with opaque colony phenotype. Opaque colony variants of strain F62 attach better to HeLa 229 and Flow 2000 cells than do transparent colony variants (4) . One PII (leukocyte association factor), from strain MS11, promotes attachment to leukocytes (6, 7, 17) . Other PIIs promote attachment to other types of eucaryotic cells (9, 15) .
The attachment function of a surface protein, such as PIT or pili, can be studied by showing that antibodies directed against the protein inhibit attachment (13, 21) . Antiserum prepared against leukocyte association factor inhibited gonococcal attachment to polymorphonuclear cells (7) . Also, antiserum prepared against pili inhibited attachment to buccal epithelial cells (18) .
Our studies have identified a PII in gonococcus strain FA1090 which may act as a mediator of attachment to HeLa cells. We employed a highly specific monoclonal antibody (11) directed against the PIT in our attachment assays. The influence of the monoclonal antibodies on attachment was studied by fluorescent microscopy and radiolabel techniques. The results showed that the PII-specific monoclonal antibody inhibited the PII-mediated attachment to HeLa cells.
MATERIALS AND METHODS
SDS-PAGE. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by Laemmli (8) . An Iodination procedures. Staphylococcus aureus protein A and the SDS-PAGE molecular weight markers were iodinated by the chloramine-T method (1) . Free iodine was removed by gel filtration through a Sephadex G-25 column, which was equilibrated in phosphate-buffered saline (PBS). Intact gonococci from the two colony variants of strain FA1090 were iodinated with a lactoperoxidase-catalyzed reaction (19) . Briefly, 0.1 mCi of 1251, 5 mM P-D-glucose, 20 ,ug of lactoperoxidase, and 0.2 U of glucose oxidase in 1 ml of PBS were combined with intact gonococci in a total volume of 1 ml for 10 min at room temperature. The gonococci were centrifuged and washed in PBS to remove unbound iodine.
Hybridoma selection and antibody production. Hybridomas were produced and screened, ascites were induced with hybridoma clones 1090-10.1 and 1035-4, and ascitic fluids were collected as previously described (11) .
Antibody specificity assay. Proteins were transferred from SDS-polyacrylamide gels to nitrocellulose paper electrophoretically, overnight, at 100 mA in a TransBlot apparatus (BioLad Laboratories). The "Western blotting" procedure of Burnette (2) was used, except that PBS was substituted for Tris-saline. Iodinated molecular weight markers were not incubated with antibody. The X-ray film was exposed to the antigen- HeLa cells. HeLa 229 cells were maintained in Eagle minimal essential medium with 10% heat-inactivated calf serum, 2.5 ,ug of fungizone per ml, 50 ,ug of gentamicin per ml, and 100 U of penicillin per ml (3). HeLa cells were removed from two 150-cm2 flasks with 0.1 mg of pancreatin per ml, 0.6 mg of trypsin per ml, and 0.5 mg of EDTA per ml, and then suspended at 125I-labeled intact gonococci, strain FA1090 PII+ or FA1090 PIP-, were incubated with monoclonal antibody 1090-10.1 or 1035-4 for 90 min at room temperature. The inocula were centrifuged, suspended in medium 199, and diluted 10-fold in medium 199. Cover slips of HeLa cells were washed in medium 199, and then 2 ml of an inoculum was added to each cover slip. The cover slips were incubated without shaking at 37°C for 30 min, the inocula were removed, and the cover slips were washed and counted.
The HeLa cells from one or two cover slips incubated with inoculum or medium alone were scraped off with a rubber policeman and dispersed in 1 (Fig. 1), The standards and the bacteria were solubilized in SDS-PAGE sample buffer at the temperature and for the time indicated in parentheses. The lactoperoxidase-catalyzed iodination of intact organisms and their analysis by autoradiography after SDS-PAGE demonstrated that the PII from the PlIl variant was a surface protein (Fig. 2) .
The mouse monoclonal antibody 1090-10.1 was specific for the PII of strain FA1090 PII+. This was demonstrated by a Western blotting reaction and autoradiography (Fig. 3) . There was no reaction between the proteins expressed by strain FA1090 PIP and monoclonal antibody 1090-10.1, nor was there a reaction between monoclonal antibody 1035-4 and the Pll of either variant by the Western blot assay.
The concentration of ascitic fluid protein (clone 1090-10.1) for maximal binding to the PII+ variant (_107 CFU) was determined to be 0.34 mg of protein per ml. The PIP-variant did not bind ascitic fluid proteins. At higher concentrations of ascitic fluid, a decrease in the gonococcal-associated 1251 counts per minute per CFU was observed. The 0.34-mg/ml concentration of ascitic fluid protein was maintained in the attachment assays. Ascitic fluid protein (clone 1035-4) did not bind to PII+ organisms in this assay.
The effect of monoclonal antibody 1090-10.1 on the attachment of strain FA1090 organisms to HeLa cells was studied with radiolabeled gonococci. Monoclonal antibody 1090-10.1 either had no effect or appeared to cause an increase in gonococcal binding of the PII+ organisms in comparison with the control antibody 1035-4 (Table 1) . Also, the number of PII+ organisms that attached when treated with monoclonal antibody 1090-10.1 was greater than the number that attached without it (data not shown). This apparent stimulation of attachment was due to the clumping or agglutination of the bacteria before their attachment to HeLa cells, as evidenced by at least a 50% drop in their numbers in the inoculum for the PlIl organisms treated with antibody 1090-10.1 as compared with the numbers in antibody 1035-4 treated controls.
To help counteract the clumping, GAM Fab were added to the four inocula before addition to HeLa cells. Monoclonal antibody 1090-10.1-treated strain FA1090 PII+ cell attachment was significantly decreased (P < 0.05) in two of the three experiments compared with the experiments in which strain FA1090 PII+ was incubated with control monoclonal antibody 1035-4 and GAM Fab (Table 1) . Attachment by the control Pll-variant was not affected by either antibody (Table 1) . ococci as well as a lower number of bound gonococcal units per HeLa cell (Table 2) . DISCUSSION N. gonorrhoeae Plls are putative attachment effectors for eucaryotic cells (7, 17, 20) . Our investigation has provided evidence that a PII of N. gonorrhoeae FA1090 may act as an attachment effector to HeLa cells. The results meet the criteria indicating protein-mediated attachment as outlined by Watt et al. (21) . First, the protein must be a surface component. The 30 kDa Pll of N. gonorrhoeae FA1090 is a surface protein, as evidenced by the 1251 labeling of intact organisms (Fig. 2) .
A second criterion is that the bacteria which do not have the surface protein do not attach. The number of strain FA1090 Pll-units which attached to the HeLa cells was less than one-half that for the PII' variants (1.64 versus 3.75) in the presence of control antibody. The number of attached strain FA1090 PII-units was not affected by either antibody ( Table 2 ), suggesting that the PII could enhance attachment. The radiolabel studies were not as conclusive, perhaps due to nonspecific or PII-mediated aggregation or clumping of the PII+ variants. This clumping would have yielded a decreased number of CFU per milliliter, resulting in a decreased number of gonococcal units available for binding while increasing the radioactivity count in the inoculum. Calculations of the percent inoculum bound for PII+ organisms yielded To quantitate the clumping of strain FA1090 PII+, HeLa cells and attached gonococci were counted after being stained with acridine orange by using fluorescent microscopy. A gonococcal unit was a single organism, a pair, or a clump. It was apparent that the number of gonococci per clump was greater for monoclonal antibody 1090-10.1-treated strain FA1090 Pll+ than for the other three inocula ( (Fig. 1) were transferred to nitrocellulose paper. The Western blotting assay for reactive antigens employed the Pll-specific monoclonal antibody 1090-10.1. Lanes: (A) 125I-labeled molecular weight markers not exposed to antibodies; PII+ solubilized at (B) 37 or (C) 100°C; and PIP-solubilized at (D) 37 or (E) 100°C. VOL. 42, 1983 on October 28, 2017 by guest http://iai.asm.org/ Downloaded from a lower value than would have been obtained had it been possible to count individual bacteria. Thus, a smaller difference in the percent inoculum bound (e.g., 1.0 versus 1.3) between the PIP and PII+ variants was found in the radiolabel studies.
The third criterion indicating protein-mediated attachment is that a highly specific antibody directed against the surface protein should inhibit attachment of the bacteria. Our gonococcal attachment assays were performed with the monospecific antibody 1090-10.1 (11 molecules and resulted in the drop in counts per minute per CFU at higher ascitic fluid protein concentrations.
The relatively low levels of attachment for the PII+ variant, 0.7 to 2.2% of the inoculum (Table  1) , could be due to the eucaryotic cell substrate used. Previously, Swanson et al. (15) showed that a nonpiliated T4* colony type with the PIT leukocyte association factor was substrate specific. They showed that 3.9% of the T4* inoculum bound to human leukocytes, whereas only 1.9% of the inoculum bound to HeLa cells. The strain FA1090 PII+ organism could exhibit this type of substrate specificity; however, we did not examine substrate specificity.
One strain of N. gonorrhoeae can make multiple PITs, and these appear to be antigenically heterogeneous (J. Swanson, Int. Conf. Path. Neisseria, Montreal, Canada, August 1982). Additionally, the different Plls appear to have different eucaryotic cell attachment specificities (7, 20) . It is interesting that one strain of N. gonorrhoeae can make a series of proteins, such as the PITs, which may function both to circumvent immune response by antigenic variation and possibly to enhance attachment to mucosal cells at different anatomic sites in men and women. Our studies have shown that monoclonal antibodies are useful reagents for experiments which will further the understanding of these interesting N. gonorrhoeae characteristics.
